DE60023898D1 - Antipsychotische n-aralkyl cyclische amine - Google Patents

Antipsychotische n-aralkyl cyclische amine

Info

Publication number
DE60023898D1
DE60023898D1 DE60023898T DE60023898T DE60023898D1 DE 60023898 D1 DE60023898 D1 DE 60023898D1 DE 60023898 T DE60023898 T DE 60023898T DE 60023898 T DE60023898 T DE 60023898T DE 60023898 D1 DE60023898 D1 DE 60023898D1
Authority
DE
Germany
Prior art keywords
antipsychotic
aralkyl
cyclic amine
cyclic
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60023898T
Other languages
English (en)
Other versions
DE60023898T2 (de
Inventor
Robert Boigegrain
Martine Bourrie
Pierre Lair
Raymond Paul
Martine Poncelet
Jean-Claude Vernieres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Application granted granted Critical
Publication of DE60023898D1 publication Critical patent/DE60023898D1/de
Publication of DE60023898T2 publication Critical patent/DE60023898T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60023898T 1999-07-02 2000-06-27 Antipsychotische n-aralkyl cyclische amine Expired - Lifetime DE60023898T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9908532A FR2795724B1 (fr) 1999-07-02 1999-07-02 Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant
FR9908532 1999-07-02
PCT/FR2000/001790 WO2001002380A1 (fr) 1999-07-02 2000-06-27 N-aralkyl amines cycliques antipsychotiques

Publications (2)

Publication Number Publication Date
DE60023898D1 true DE60023898D1 (de) 2005-12-15
DE60023898T2 DE60023898T2 (de) 2006-08-10

Family

ID=9547628

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60023898T Expired - Lifetime DE60023898T2 (de) 1999-07-02 2000-06-27 Antipsychotische n-aralkyl cyclische amine

Country Status (31)

Country Link
US (1) US6908914B1 (de)
EP (1) EP1196403B1 (de)
JP (1) JP4931309B2 (de)
KR (1) KR100760446B1 (de)
CN (1) CN1156462C (de)
AR (1) AR029374A1 (de)
AT (1) ATE309231T1 (de)
AU (1) AU778299B2 (de)
BG (1) BG65209B1 (de)
BR (1) BR0012463B1 (de)
CA (1) CA2376691C (de)
CO (1) CO5021196A1 (de)
CZ (1) CZ300936B6 (de)
DE (1) DE60023898T2 (de)
DK (1) DK1196403T3 (de)
EA (1) EA004048B1 (de)
ES (1) ES2250160T3 (de)
FR (1) FR2795724B1 (de)
HK (1) HK1043122A1 (de)
HR (1) HRP20010949B1 (de)
HU (1) HU228983B1 (de)
IL (2) IL147069A0 (de)
ME (1) MEP25508A (de)
MX (1) MXPA01013207A (de)
NO (1) NO322230B1 (de)
NZ (1) NZ516342A (de)
RS (1) RS50266B (de)
TW (1) TWI285640B (de)
UA (1) UA71009C2 (de)
WO (1) WO2001002380A1 (de)
ZA (1) ZA200200018B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003017764A1 (de) * 2001-08-23 2003-03-06 Bayer Cropscience S.A. Substituierte propargylamine
EP1940389A2 (de) 2005-10-21 2008-07-09 Braincells, Inc. Modulation von neurogenese durch pde-hemmung
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
EP2021000A2 (de) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenese mittels angiotensin-modulation
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790971A (fr) * 1971-11-09 1973-05-07 Janssen Pharmaceutica Nv Metode ter voorkoming van patologische reakties die de funktie van het komplement vereisen
JPS504086A (de) * 1973-01-18 1975-01-16
US4104383A (en) * 1973-11-02 1978-08-01 C M Industries Derivatives of phenylpropenylamine
GB1475314A (en) * 1973-11-02 1977-06-01 Cm Ind Phenyl-propylamine derivatives
US4855462A (en) * 1988-06-17 1989-08-08 Pennwalt Corporation Antihistamines
EP0347123A3 (de) * 1988-06-17 1991-07-03 Fisons Corporation Dibenzo-cycloheptenyl-, -cycloheptyl- und -oxepinylamine mit antihistaminischer Aktivität
US4912222A (en) * 1988-06-17 1990-03-27 Fisons Corporation Antihistamines related to cyproheptadine
FR2663328B1 (fr) * 1990-06-14 1994-08-05 Sanofi Sa Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
EP0591426A4 (en) * 1991-06-27 1996-08-21 Univ Virginia Commonwealth Sigma receptor ligands and the use thereof
JP3199405B2 (ja) * 1991-08-30 2001-08-20 生化学工業株式会社 肝細胞球状集塊化剤及び球状集塊化肝細胞の製造方法
US5486517A (en) * 1994-05-10 1996-01-23 Warner-Lambert Company Benzimidazoles and imidazopyridines as central nervous system agents
FR2751645B1 (fr) * 1996-07-29 1998-12-24 Sanofi Sa Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales
CN1183116C (zh) * 1997-03-18 2005-01-05 史密丝克莱恩比彻姆有限公司 取代的异喹啉类衍生物、含有它们的药物组合物、其制备方法及用途

Also Published As

Publication number Publication date
JP2003503487A (ja) 2003-01-28
ZA200200018B (en) 2003-01-02
YU91101A (sh) 2004-09-03
HUP0202200A2 (en) 2002-10-28
ES2250160T3 (es) 2006-04-16
NO20016392L (no) 2002-03-04
US6908914B1 (en) 2005-06-21
MEP25508A (en) 2010-06-10
EA004048B1 (ru) 2003-12-25
CN1156462C (zh) 2004-07-07
CZ300936B6 (cs) 2009-09-16
CZ20014697A3 (cs) 2002-04-17
HK1043122A1 (zh) 2002-09-06
HU228983B1 (en) 2013-07-29
EP1196403A1 (de) 2002-04-17
IL147069A (en) 2006-09-05
FR2795724A1 (fr) 2001-01-05
KR20020016877A (ko) 2002-03-06
CA2376691A1 (en) 2001-01-11
CO5021196A1 (es) 2001-03-27
EP1196403B1 (de) 2005-11-09
AU778299B2 (en) 2004-11-25
JP4931309B2 (ja) 2012-05-16
NO20016392D0 (no) 2001-12-27
KR100760446B1 (ko) 2007-10-04
DE60023898T2 (de) 2006-08-10
HRP20010949B1 (en) 2006-06-30
CA2376691C (en) 2009-09-01
WO2001002380A8 (fr) 2001-06-28
MXPA01013207A (es) 2002-06-21
NZ516342A (en) 2003-08-29
HUP0202200A3 (en) 2002-12-28
FR2795724B1 (fr) 2002-12-13
PL356186A1 (en) 2004-06-14
CN1367783A (zh) 2002-09-04
TWI285640B (en) 2007-08-21
BG106255A (en) 2002-10-31
IL147069A0 (en) 2002-08-14
RS50266B (sr) 2009-07-15
AR029374A1 (es) 2003-06-25
UA71009C2 (uk) 2004-11-15
BR0012463A (pt) 2002-04-02
HRP20010949A2 (en) 2003-04-30
BR0012463B1 (pt) 2014-11-04
NO322230B1 (no) 2006-08-28
EA200101209A1 (ru) 2002-06-27
DK1196403T3 (da) 2006-03-20
BG65209B1 (bg) 2007-07-31
ATE309231T1 (de) 2005-11-15
AU5992400A (en) 2001-01-22
WO2001002380A1 (fr) 2001-01-11

Similar Documents

Publication Publication Date Title
DE60224521D1 (de) N-aroyl zyklische amine
NO20020307D0 (no) N-(indolkarbonyl)piperazinderivater
NO20013451D0 (no) 1-Heterocyklus-substituerte diarylaminer
IT1308096B1 (it) Convertiplano
DE60010586D1 (de) Verbesserungen bezüglich injektionsvorrichtungen
DE60025345D1 (de) Spritzanordnung
DE60044166D1 (de) Hörkapsel
DE50008281D1 (de) Spinnvorrichtung
DE60038157D1 (de) Baumaschine
DE29904636U1 (de) Drehkreisel
DE60037278D1 (de) Tintenset
ATE309231T1 (de) Antipsychotische n-aralkyl cyclische amine
DE60005110D1 (de) Mikrometer
DE60018760D1 (de) Schiebernadel
DE60110046D1 (de) Cyclische hexapeptidderivate
DE50003014D1 (de) N-substituierte perhydrodiazine
FR2789340B1 (fr) Machine de marquage
DE60020323D1 (de) Schwingungsdämpfer
SI1196403T1 (sl) Antipsihoticni ciklicni N-aralkil amini
DE60021027D1 (de) Abtastvorrichtung
DE29902285U1 (de) Turbogeneratorvorrichtung
IT247019Y1 (it) Macchina garzatrice
FR2792876B1 (fr) Machine de marquage
DE10082329D2 (de) Lerngerät
FR2797145B1 (fr) Machine desileuse-melangeuse-distributrice perfectionnee

Legal Events

Date Code Title Description
8364 No opposition during term of opposition